(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)[(1R)-1-phenylethyl]amine 422509-53-3 (+)-N-1(R1-PHENYLETHYL)-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE, (11B,S);(R)-N-(1-PHENYLETHYL)DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A']DINAPHTHALEN-4-YL)[(1R)-1-PHENYLETHYL]AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)[(1R)-1-PHENYLETHYL]AMINE;(S)-N-(1-PHENYLETHYL)DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE;(S,R)-(+)-(3,5-DIOXA-4-PHOSPHACYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)-(1-PHENYLETHYL)AMINE;(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)[(1R)-1-phenylethyl]amine SC11357
| CAS 号 | 422509-53-3 |
| 分子式 | C28H48NO2P |
| 分子量 | 461.66 g/mol |
| 分类 | 药物标准品 / 原料药标准品 |
| 库存状态 | 现货 |
CAS 422509-53-3 对应的(<I>S</I>,<I>R</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a′]二萘-4-基)-(1-苯基乙基)胺((S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)[(1R)-1-phenylethyl]amine 422509-53-3 (+)-N-1(R1-PHENYLETHYL)-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE, (11B,S);(R)-N-(1-PHENYLETHYL)DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A']DINAPHTHALEN-4-YL)[(1R)-1-PHENYLETHYL]AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)[(1R)-1-PHENYLETHYL]AMINE;(S)-N-(1-PHENYLETHYL)DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE;(S,R)-(+)-(3,5-DIOXA-4-PHOSPHACYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)-(1-PHENYLETHYL)AMINE;(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)[(1R)-1-phenylethyl]amine SC11357)为 CATO 佳途药物标准品产品线成员。分子式 C28H48NO2P,分子量 461.66。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认,质量稳定可溯源。
(<I>S</I>,<I>R</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并2,1-a:3,4-a′二萘-4-基)-(1-苯基乙基)胺的产生途径与其化学式中甾体骨架,酰胺类,有机磷,含羟基,含醚键密切相关,该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 CAS编号 422509-53-3 对应的化合物(<I>S</I>,<I>R</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并2,1-a:3,4-a′二萘-4-基)-(1-苯基乙基)胺(英文标识 (S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta2,1-a;3,4-a'dinaphthalen-4-yl)(1R)-1-phenylethylamine 422509-53-3 (+)-N-1(R1-PHENYLETHYL)-DINAPHTHO2,1-D:1',2'-F1,3,2DIOXAPHOSPHEPIN-4-AMINE, (11B,S);(R)-N-(1-PHENYLETHYL)DINAPHTHO2,1-D:1',2'-F1,3,2DIOXAPH
应用场景:针对化学分析用途,(<I>S</I>,<I>R</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并 2,1-a:3,4-a′ 二萘-4-基)-(1-苯基乙基)胺((S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta 2,1-a;3,4-a' dinaphthalen-4-yl) (1R)-1-phenylethyl amine 422509-53-3 (+)-N-1(R1-PHENYLETHYL)-DINAPHTHO 2,1-D:1',2'-F 1,3,2 DIOXAPHOSPHEPIN-4-AMINE, (11B,S);(R)-N-(1-PHENYLETHYL
| 中文名称 | (<I>S</I>,<I>R</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a′]二萘-4-基)-(1-苯基乙基)胺 |
| 分子式 | C28H48NO2P |
| 分子量 | 461.66 g/mol |
| 外观形态 | 类白色至淡黄色结晶性粉末 |
| 纯度 | 97%+ |
| 储存条件 | 室温保存,避光 |
| 溶解性参考 | 可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO |
| 稳定性 | 空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射 |
| 化合物类型 | 药物标准品 |
| 子类 | 原料药标准品 |
| 不饱和度(DBE) | 5.5 |
| UV特征 | 有紫外吸收 |
| 结构特征 | 含芳环 |
| CAS登记年份(估) | 2025年 |
| 含氮原子数 | 1 |